"Competitive quenching": A mechanism by which perihydroxylated perylenequinone photosensitizers can prevent adverse phototoxic damage caused by verteporfin during photodynamic therapy

Photochemistry and Photobiology

Volumn 83, Issue 5, 2007, Pages 1270-1277

  Lavie, Gad ^a   Barliya, Tilda ^a   Mandel, Mathilda ^a   Blank, Michael ^b   Ron, Yonina ^b   Orenstein, Arie ^a   Livnat, Tami ^a   Friedman, Noga ^c   Weiner, Lev ^c   Sheves, Mordechai ^c   Weinberger, Dov ^b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

PHOTOSENSITIZING AGENT; PORPHYRIN; QUINONE DERIVATIVE; VERTEPORFIN;

ARTICLE; CELL LINE; DRUG EFFECT; HYDROXYLATION; RETINA;

CELL LINE; HYDROXYLATION; PHOTOSENSITIZING AGENTS; PORPHYRINS; QUINONES; RETINA;

EID: 34548744641     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1751-1097.2007.00171.x     Document Type: Article

References (17)

1. Hilf, R. (1992) Cellular targets of photodynamic therapy as a guide to mechanism. In Photodynamic Therapy. Basic Principles and Clinical Applications (Edited by B. W. Henderson T. J. Dougherty pp. 47 52. Marcel Dekker, New York.
2. Star, W. M., J. P. A. Marijnissen, A. E. van den Berg-Blok, A. A. C. Versteeg, N. A. P. Franken H. S. Rheinolds (1986) Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers. Cancer Res. 46, 2532 2540.
3. Fingar, V. H., T. J. Wieman, S. A. Wiehle P. B. Cerrito (1992) The role of microvascular damage in photodynamic therapy: The effect of treatment on vessel constriction, permeability and leukocyte adhesion. Cancer Res. 52, 4914 4921.
4. Schmidt-Erfurth, U., S. Michels, I. Barbazetto H. Laqua (2002) Photodynamic effects on choroidal neovascularization and physiological choroid. Invest. Ophthalmol. Vis. Sci. 43, 830 841.
5. Brown, S. B. K. J. Mellish (2001) Verteporfin: A milestone in ophthalmology and photodynamic therapy. Expert. Opin. Pharmacother. 2, 351 361.
6. Schmidt-Erfurth, U., J. W. Miller, M. Sickenberg, H. Laqua, I. Barbazetto, E. S. Gragoudas, L. Zografos, B. Piguet, C. J. Pournaras, G. Donati, A. M. Lane, R. Birngruber, H. van den Berg, H. A. Strong, U. Manjuris, T. Gray, M. Fsadni N. M. Bressler (1999) Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: Results of retreatments in a phase 1 and 2 study. Arch. Ophthalmol. 117, 1177 1187.
7. Miller, J. W., U. Schmidt-Erfurth, M. Sickenberg, C. J. Pournaras, H. Laqua, I. Barbazetto, L. Zografos, B. Piguet, G. Donati, A. M. Lane, R. Birngruber, H. van den Berg, A. Strong, U. Manjuris, T. Gray, M. Fsadni, N. M. Bressler E. S. Gragoudas (1999) Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: Results of a single treatment in a phase 1 and 2 study. Arch. Ophthalmol. 117, 1161 1173.
8. Weinberger, D., M. Blank, Y. Ron, M. Mandel, T. Livnat, M. Lusky, T. Barliya, D. Gaaton, A. Orenstein G. Lavie (2005) Competitive quenching: A possible novel approach in protecting RPE cells from damage during PDT. Curr. Eye Res. 30, 269 277.
9. Redepenning, J. N. Tao (1993) Measurement of formal potentials for hypericin in dimethylsulfoxide. Photochem Photobiol. 58, 532 535.
10. Lavie, G., Y. Mazur, D. Lavie D. Meruelo (1994) The chemical and biological properties of hypericin - A compound with a broad spectrum of biological activities. Med. Res. Rev. 15, 111 119.
11. Freeman, D., L. Konstantinovski Y. Mazur (2001) The structure of hypericin in solution. Searching for hypericin's 1,6 tautomer. Photochem. Photobiol. 74, 206 210.
12. Lavie, G., C. Kaplinsky, A. Toren, I. Aizman, D. Meruelo, Y. Mazur M. Mandel (1999) A photodynamic pathway to apoptosis and necrosis induced by dimethyl tetrahydroxy helianthrone and hypericin in leukemic cells. Possible relevance to photodynamic therapy. Br. J. Cancer 79, 423 432.
13. Edgell, C. J., C. C. McDonald J. B. Graham (1983) Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc. Natl Acad. Sci. USA 80, 3734 3737.
14. Rieber, A. J., H. S. Marr, M. B. Comer C. J. Edgell (1993) Extent of differentiated gene expression in the human endothelium-derived EA.hy926 cell line. Thromb. Haemost. 69, 476 480.
15. Keisari, Y. (1992) A colorimetric microtiter assay for the quantitation of cytokine activity on adherent cells in tissue culture. J. Immunol. Methods 146, 155 161.
16. Mossman, T. (1983) Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55 63.
17. Aveline, B. M., T. Hasan R. W. Redmond (1995) The effects of aggregation, protein binding and cellular incorporation on the photophysical properties of benzoporphyrin derivative monoacid ring A (BPDMA). J. Photochem. Photobiol. B, Biol. 30, 161 169.